Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical recalls Hydroxocobalamin Injection, HYDROXOCOBALAMIN 5MG/ML INJECTABLE, For IV, IM Use, Refrigerate, 30 mL Multi-dose Vial, Rx
Recalled March 11, 2020 · FDA recall D-0957-2020 · Fusion IV Pharmaceuticals, Inc.
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
N/A
Sold at
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic
Description
Lack of Assurance of Sterility
Product
Hydroxocobalamin Injection, HYDROXOCOBALAMIN 5MG/ML INJECTABLE, For IV, IM Use, Refrigerate, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0339-3
Manufacturer(s)
Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →